TECOVIRIMAT
| Brand name | TPOXX |
|---|---|
| Active ingredient | TECOVIRIMAT |
| Strength | 200MG |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2018 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11890270 | August 2032 | use U-2346 |
| 7737168 | September 2031 | use U-2346 |
| 9339466 | March 2031 | substance, product |
| 12433868 | March 2031 | product |
| 8039504 | July 2027 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.